Replies to post #328830 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

We are not waiting.

Site transfer was approved this quarter.

-- Other products, Loxapine. The site transfer to Elite's facility for Loxapine capsules was approved this quarter. We are finalizing arrangements with the marketing partner at this time. We had three marketing partner potentials, now it down to one, and we are very close at concluding an agreement with the marketing partner. We expect the product launch next quarter. This product has an IMS or IQVIA data of $6 million and currently there are four approvals.

And also, on the shortage page, looks like Loxapine is still in short supply, they just updated, Teva is making it but looks limited

https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm

go to page 5. in the meantime, we wait for site transfer.